Navigation Links
Wistar Institute team finds key target of aging regulator
Date:6/10/2009

Researchers at The Wistar Institute have defined a key target of an evolutionarily conserved protein that regulates the process of aging. The study, published June 11 in Nature, provides fundamental knowledge about key mechanisms of aging that could point toward new anti-aging strategies and cancer therapies.

Scientists have long known that a class of proteins called sirtuins promotes fitness and longevity in most organisms ranging from single-celled yeast to mammals. At the cellular level, sirtuins protect genome integrity, enhance resistance to adverse stresses, and antagonize senescence. However, the underlying molecular mechanisms have remained poorly understood. The team, led by senior author Shelley Berger, Ph.D., Hilary Koprowski Professor at The Wistar Institute, demonstrated for the first time a molecular target for a member of this class, Sir2, in regulation of aging in yeast cells. Sir2 removes an acetyl group attached to a specific site (lysine at position 16 or K16) on histone H4histones are proteins that package and organize the long strands of DNA within the nucleus and also are central regulators in turning genes on and off. The study reveals that removal of this acetyl group by Sir2 near the chromosome endsthe telomeresis important for yeast cells to maintain the ability to replicate. Researchers found that Sir2 levels decline as cells age, and there is a concomitant accumulation of the acetylation mark along with disrupted histone organization at telomeres.

Deacetylation of H4K16 by Sir2 and consequent telomere stability play a major role in maintaining long lifespan in yeast. Since sirtuins deacetylate many different proteins, these results clarify a key role of Sir2 protein in control of lifespan.

"Some modifications on histones, like this acetylation on histone H4 lysine 16, are persistent and are maintained through generations of cell divisions. This DNA-independent inheritance is called epigenetics," Berger says. "Characteristic epigenetic features have been discovered for various developmental processes in recent years. Understanding epigenetic changes associated with aging is a hugely exciting direction in aging research. It will provide insights and ideas not only for new therapies to regulate cells that have lost control of proliferation, such as 'immortal' cells found in cancers, but also for new strategies to maintain health and fitness."

"We plan to continue to search for new targets of Sir2 and other aging regulators," says lead author Weiwei Dang, Ph.D., a postdoctoral scientist working with Berger. "We are designing unbiased screens for other aging targets and mechanisms in chromatin. Using yeast as our aging model enables us to do many discovery screens that are impossible with other, more complex organisms. Yet it is remarkable that many of these chromatin mechanisms associated with yeast could turn out to be relevant even for aging human cells."


'/>"/>

Contact: Susan Finkelstein
sfinkelstein@wistar.org
215-898-3943
The Wistar Institute
Source:Eurekalert

Related medicine news :

1. Los Angeles Times writer wins Wistar Institute Science Journalism Award
2. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
3. Novel vaccine concept developed by scientists at the Wistar Institute
4. Cortiva Institute to Open Branch Location in Woodridge, IL
5. Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
6. Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany
7. Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Incs. GCS-100 Molecule
8. Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer
9. Z Trim Holdings Abstract Selected as Best of the Best by Institute of Food Technologists
10. Council for American Medical Innovation and The Aspen Institute Bring Leaders Together In Washington, D.C., To Discuss The Economic Impact Of Medical Science and Discovery, and Policies Needed To Maintain U.S. Leadership at Best And Brightest Forum On Me
11. Florida Hospital Cardiovascular Institute Completes House-Wide Implementation of the LifeSync(R) Wireless ECG System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... VA (PRWEB) , ... April 27, 2017 , ... ... application containerization, today announced an exhibitor sponsorship at MobileIron Live! 2017 ... and new technologies for an immersive, educational approach to helping organizations maximize the ...
(Date:4/27/2017)... , ... April 27, 2017 , ... Offering the purest ... an oil many times purer and more potent than the market has seen before. ... Gstaad, Switzerland, as well as a patented chromatography process for extraction, to produce its ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to announce that ... at the upcoming Aesthetic Meeting. Held in San Diego, at the San Diego Convention ... will lend their expertise to the Premier Global Hot Topics session, speaking on genital ...
(Date:4/26/2017)... Louis, Missouri (PRWEB) , ... April 26, 2017 ... ... cost, quality and clinical outcomes, today released the podcast, “Make Plans for ... in bringing value-based payment into the physician's office and how physicians and other ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ATA 2017 President’s Awards recipients, comprised of organizations and individuals who have ... , The ATA 2017 President’s Awards recognize individuals and organizations on the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... and Gynecology markets with innovative and proprietary products, ... Company as Senior Vice President, Marketing & Business ... will report directly to Darin Hammers , ... delighted that Ash has joined the Cogentix team," ...
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: